Identification of a new tadalafil analogue found in a dietary supplement

A new tadalafil analogue, acetaminotadalafil, was detected by HPLC in a bulk powder that is being used as an ingredient formanufacturing dietary supplements. The analogue was isolated by semi-preparative HPLC. A chemical structure of the new compound was elucidated by HPLC, LC-quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS), nuclear magnetic resonance (NMR), infrared (IR) and circular dichroism (CD) spectroscopy. The compound was identified as an acetylatedcompound of aminotadalafil. The structure of the previous unknown compound was confirmed as (6R,12aR)-2-acetamino-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione and named as acetaminotadalafil.     

非对映选择性合成他达那非

以D-色氨酸为起始原料经酯化、Pictect-Spengler反应、酰化和氨解-环合四步制备新的磷酸二酯酶5抑制剂他达那非,总收率为66.8%。在Pictect-Spengler反应中采用非对映控制方法高选择性地合成cis-β-咔啉关键中间体,避免了trans-异构体的分离。     

Transdermal Delivery of Tadalafil. I. Effect of Vehicles on Skin Permeation

Transdermal delivery that avoids the presystemic disposition can provide an alternative to oral administration of tadalafil. Accordingly, the aim of this study was to select the best vehicle as the first step in optimization of tadalafil transdermal delivery. The vehicles were used neat or in selected binary combinations and were evaluated for drug solubilization and transdermal delivery. The drug solubility in pure vehicles were ranked as polyethylene glycol (PEG) 400 >?propylene glycol (PG) >?ethanol >?ethyl oleate (EO) >?isopropyl myristate (IPM) >?water. The solubility in binary systems containing ethanol at 2:1 ratios with EO or IPM was greater than that obtained with pure ethanol, EO, or IPM. This effect could be due to the cosolvency effect. The transdermal drug delivery from pure vehicles was ranked as IPM >?EO >?ethanol >?PG >?PEG >?water. The delivery from binary mixtures of ethanol with either IPM or EO was higher than that obtained from pure solvents with the delivery increasing with increasing ethanol concentration in the mixtures. The delivery from binary mixtures was synergistic rather than additive. The study thus demonstrated a potential of tadalafil transdermal delivery. Binary combinations of ethanol with either IPM or EO provided the first step forward toward the development of transdermal delivery system for tadalafil.     

Identification of a new type tadalafil analogue in a supplement product

A novel compound structurally similar to tadalafil was found in a dietary supplement by adulterants screening test and isolated by column chromatography. After analysis by accurate mass, nuclear magnetic resonance (NMR) and X-ray, the structure of this novel tadalafil analogue was determined as (5R, 16R)-5-(1,3-benzodioxol-5-yl)-2- (3-ethypentan-3-yl)-15,16-dihydro(1H-imidazo[1,5-a]pyrido)[3,4-b]indol-1,3-dion     

纸喷雾离子化质谱法快速筛查保健食品中违禁添加的磷酸二酯酶5抑制剂

目的建立纸喷雾离子化质谱(PSI-MS)法快速检测保健食品中3种非法添加的磷酸二酯酶5(PDE5)抑制剂(西地那非、伐地那非和他达拉非)的方法。方法利用PSI-MS法对样品中非法添加物进行初步定性鉴别,并通过内标法进行半定量分析。结果 24种包括胶囊、片剂、丸剂、粉末、酒剂、糖浆及口服液等剂型在内的待测市售保健品的PSI-MS检测结果与HPLC-UV检测结果基本一致。各目标物在一定范围内线性关系良好,相关系数r~2均0.99,检出限均在1.0 mg/L以下,相对标准偏差为20%~24%。结论本方法快速、准确、专属性强,适用于大批量复杂基质样品中PDE5抑制剂的快速筛查。     

他达拉非合成研究进展

他达拉非(Tadalafil)是一种口服磷酸二酯酶V型(PDE5)抑制剂,用于治疗男性勃起功能障碍(MED)。该化合物的合成路线主要以D-色氨酸和胡椒醛为原料,进行包括Pictet-Spengler反应形成四氢-β-咔啉结构,氯乙酰化反应和甲胺环合反应。到目前为止,报道其合成的文献有数十篇,本文即对合成路线进行综述。     

Sildenafil and analogous phosphodiesterase type 5 (PDE-5) inhibitors in herbal food supplements sampled on the Dutch market

Herbal food supplements, claiming to enhance sexual potency, may contain deliberately added active pharmacological ingredients (APIs) that can be used for the treatment of erectile dysfunction (ED). The aim of this study was to determine whether herbal food supplements on the Dutch market indeed contain APIs that inhibit phosphodiesterase type 5 (PDE-5) inhibitors, such as sildenafil and analogous PDE-5 inhibitors. Herbal food supplements intended to enhance sexual potency (n = 71), and two soft drinks, were sampled from 2003 up to and including 2012. In 23 herbal supplements, nine different PDE-5 inhibitors were identified; in a few cases (n = 3), more than one inhibitor was indentified. The presence of these APIs was however not stated on the label. The concentrations of PDE-5 inhibitors per dose unit were analysed. Furthermore, the potential pharmacologically active properties of the detected PDE-5 inhibitors were estimated by using data from the scientific and patent literature regarding (1) in vitro PDE-5 activity, (2) reported effective doses of registered drugs with PDE-5 inhibitor activity and (3) similarity to other structural analogues. It was concluded that 18 of the 23 herbal food supplements, when used as recommended, would have significant pharmacological effects due to added APIs. Adequate use of existing regulation and control measures seems necessary to protect consumers against the adverse effects of these products.     

Determination of PDE-5 inhibitors and appetite suppressants in adulterated dietary supplements using LC/PDA and LC/MS

There have been a number of reports of dietary supplements contaminated with illegal adulterants that threaten consumers’ health because of their adverse pharmacological effects. In the present study, a convenient and economic method was developed to detect illegal pharmaceutics, such as PDE-5 inhibitor and appetite suppressants, using liquid chromatography (LC)/photodiode array (PDA) for screening and LC/mass spectrometry (MS) for successive confirmation. Target peaks were identified by comparison of their chromatographic retention times and PDA spectra with those of synthetic standards and finally confirmed by LC/MS. As a result, tadalafil, a PDE-5 inhibitor, and N-desmethylsibutramine, a derivative of sibutramine, were detected in various dietary supplements at concentrations of 13.5–21.9?mg and 3.0?mg per single dose, respectively. The present study will contribute to the development of an analytical method enabling rapid screening of a variety of health foods, and the result suggests that consumers should be aware of serious health risks related to these illegal compounds.     

超高效液相色谱-串联质谱法同时测定保健品中三种违禁成分

建立固相萃取-超高效液相色谱-串联质谱/质谱法(SPE-UPLC-MS/MS)测定保健品中伐地那非、西地那非、他达那非的分析方法。试样经甲醇或盐酸溶液提取,HLB固相萃取柱净化后,以乙腈和0.1%甲酸水溶液作为流动相,C18色谱柱分离,采用电喷雾离子源,正离子扫描多反应监测(MRM)模式进行检测。伐地那非、西地那非、他达那非在10~200μg/L浓度范围内呈良好线性关系,相关系数(r2)均大于0.99。空白样品加标回收率均大于75%,相对标准偏差小于8%。胶囊样品中伐地那非、西地那非、他达那非的方法检出限分别为10μg/kg、10μg/kg、20μg/kg;定量限分别为40μg/kg、40μg/kg、80μg/kg。口服液中分别为3μg/L、3μg/L、6μg/L,定量限分别为10μg/L、10μg/L、20μg/L。研究了基质效应的影响,样品基质对伐地那非、西地那非、他达那非的响应表现为抑制作用,伐地那非受到抑制作用最明显。